Stock Market Highlights: Sensex ends 579 pts higher and Nifty reclaims 17,800 as market extends gains — rupee at 79.75 vs dollar

Thank you, readers! That's all from CNBCTV18.com's live market coverage on September 20, 2022. Stay tuned for other updates on our website: CNBCTV18.com.

You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News

And on Facebook, LinkedIn, Instagram and Telegram

Download our mobile app for Android and iOS platforms

Rupee ends nearly unchanged vs US dollar

India has outperformed significantly, earnings resilient: Gautam Duggad

Gautam Duggad, Head of research-Institutional Equities at Motilal Oswal Financial Services, tells CNBC-TV18 that despite many headwinds, India has outperformed other markets significantly on the back of resilient earnings. "The diamond decade is very amply reflected in the presentations that various CEOs have made," he says. 

"The mood is quite buoyant, whether it is on consumption or financials... So far so good," he adds. 

Market At Close | Sensex and Nifty50 rise for second straight session

Here are some highlights: 

--Financial stocks continue to support headline indices

--ICICI Bank, HDFC and HDFC Bank top gainers

--Pharma stocks see buying — 3 top 5 Nifty gainers pharma stocks

--Apollo, Cipla and Sun Pharma top Nifty gainers

--Nestle, Shree Cement and Grasim top Nifty losers 

--Can Fin Homes continues to fall after CEO's resignation — down 11 percent in 2 days

--Granules, India Cements, Delta Corp, GMR and PVR top midcap losers

--Market breadth favours the bulls — advance-decline ratio at 2:1

Infosys bags order from Telenor Norway

RBI is likely to take a 50 bps rate hike in its next meeting: Hitendra Dave of HSBC India 

Hitendra Dave, HSBC India said, "India's reserves in September 2021 were at $650 billion, and forward book estimate at $40 billion." Dave said, expect significant volatility in case the fed hikes rates by 100 bps.

Biocon in focus

European Medicines Agency says biosimilar medicines approved in EU are interchangeable with an equivalent biosimilar

Buy Canara Bank, Ramco Cements: Manish Hathiramani

Here are two recommendations by Manish Hathiramani of Deen Dayal Investments:
-- Buy Canara Bank for a target of Rs 265 with a stop loss at Rs 235 
-- Buy Ramco Cements for a target of Rs 875 with a stop loss at Rs 750 

Dr Reddy’s near day's high

CNBC-TV18 Exclusive | Huge demand across our models, says M&M's Anish Shah

In an exclusive interaction with CNBC-TV18, Anish Shah of M&M says the company is partnering with large marquee investors to grow Mahindra Susten. He also says M&M is seeing huge demand across its range of models. The government has taken many proactive steps to provide stability in raw material prices, he says. 

HDFC Bank shares at day's high

Eicher, Adani Enterprises and IndusInd hit 52-week highs

Geojit rolls out MSCI indices-based equity baskets

Investment Services Company, Geojit Financial Services has launched two unique equity indexes based on the custom indexes created by MSCI. These curated model portfolio baskets are: Select, which is based on MSCI India Domestic IMI Select sub industries index; and LMS, which is based on MSCI lndia Domestic IMI Select 30 index. 

Aster DM launches rejig exercise to tap global funds for Middle East business: Moneycontrol 

Buy Sun Pharma, Page Industries: Mitessh Thakkar

Here are some recommendations by Mitessh Thakkar of earningwaves.com
-- Buy Sun Pharma for a target of Rs 920 with a stop loss at Rs 880 
-- Buy Page Industries for a target of Rs 52,000 with a stop loss at Rs 49,400